Advertisement

  • Rethinking Clinical Trials

    Could changes spurred by safety concerns during the pandemic make clinical trials more accessible to patients?

    by Charlotte Huff

  • Forward Look

    Predicting Colorectal Cancer Recurrence

    Liquid biopsy tests can find tiny amounts of disease that remain after surgery and chemotherapy.

    by Kris Conner

  • Forward Look

    What’s Next?

    Oncolytic viruses to treat pediatric glioma.

    by Natalie Slivinski

  • From the Editor-in-Chief

    The Tumor Microenvironment

    Research is leading to treatments that target cancer’s support system.

    by William G. Nelson, MD, PhD 

  • Forward Look

    First CAR-T Cell Therapy Approved for Multiple Myeloma

    Cellular immunotherapies can offer periods when people do not require treatment.

    by Christina Bennett

  • Forward Look

    Going Flat

    Most people who opt out of breast reconstruction are satisfied with their decision but are not always supported by their surgeons.

    by Kris Conner

  • Forward Look

    What’s Next?

    Using fecal transplants to improve immunotherapy response

    by Natalie Slivinski

  • Are You a Candidate for Immunotherapy?

    Tumor testing can help determine whether certain cancers are likely to respond to immunotherapy drugs.

    by Kendall K. Morgan

  • A Fast Track for Cancer Vaccines

    The rapid development of mRNA COVID-19 vaccines could spark advances in similar treatments for cancer.

    by Stephen Ornes

  • A Treatment That Came Just in Time

    Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.

    by Laurie Adami

Advertisement
Advertisement

From the AACR

Advertisement

Video

Learning Medicare’s ABCDs

Advertisement

social media

donate to the AACR